Cytochrome P450 epoxygenase metabolites of arachidonic acid (EETs) have multiple cardiovascular effects, including reduction of blood pressure, protection against myocardial ischemia-reperfusion injury, and attenuation of endothelial inflammation and apoptosis. The present study was aimed to determine potential neuroprotective roles for EETs in cerebral ischemia
Background/Aims: Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase (CYP) metabolites ...
Ischaemic stroke instigates a series of pathological mechanisms which contribute to injury. Despite ...
Soluble Epoxide Hydrolase (sEH) is a key enzyme in the metabolism and termination of action of epoxy...
Cytochrome P450 epoxygenase metabolites of arachidonic acid (EETs) have multiple cardiovascular effe...
Cytochrome P450 epoxygenases (CYP) metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs), ...
Thesis (Ph.D.)--University of Washington, 2018Epoxyeicosatrienoic acids (EETs) are metabolites of ar...
Aims: 14,15-Epoxyeicosatrienoic acid (14,15-EET) is abundantly expressed in brain and exerts protect...
Stroke and cardiac arrest (CA) both are characterized by severe fall in the cerebral blood flow (CBF...
Background: Cytochrome P450 epoxygenase 2J2 (CYP2J2) metabolizes arachidonic acids to epoxyeicosatri...
The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidoni...
Inhibition of soluble epoxide hydrolase (sEH) is a potential target of therapy for ischemic injury. ...
To investigate the effect of 14,15-EET on the parthanatos in neurons induced by cerebral ischemia an...
Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) by cytochrome (CYP) P450 epoxyge...
Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) by cytochrome (CYP) P450 epoxyge...
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United Stat...
Background/Aims: Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase (CYP) metabolites ...
Ischaemic stroke instigates a series of pathological mechanisms which contribute to injury. Despite ...
Soluble Epoxide Hydrolase (sEH) is a key enzyme in the metabolism and termination of action of epoxy...
Cytochrome P450 epoxygenase metabolites of arachidonic acid (EETs) have multiple cardiovascular effe...
Cytochrome P450 epoxygenases (CYP) metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs), ...
Thesis (Ph.D.)--University of Washington, 2018Epoxyeicosatrienoic acids (EETs) are metabolites of ar...
Aims: 14,15-Epoxyeicosatrienoic acid (14,15-EET) is abundantly expressed in brain and exerts protect...
Stroke and cardiac arrest (CA) both are characterized by severe fall in the cerebral blood flow (CBF...
Background: Cytochrome P450 epoxygenase 2J2 (CYP2J2) metabolizes arachidonic acids to epoxyeicosatri...
The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidoni...
Inhibition of soluble epoxide hydrolase (sEH) is a potential target of therapy for ischemic injury. ...
To investigate the effect of 14,15-EET on the parthanatos in neurons induced by cerebral ischemia an...
Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) by cytochrome (CYP) P450 epoxyge...
Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) by cytochrome (CYP) P450 epoxyge...
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United Stat...
Background/Aims: Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase (CYP) metabolites ...
Ischaemic stroke instigates a series of pathological mechanisms which contribute to injury. Despite ...
Soluble Epoxide Hydrolase (sEH) is a key enzyme in the metabolism and termination of action of epoxy...